SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by First Republic Investment Management Inc.

First Republic Investment Management Inc. lifted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIGet Rating) by 30.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 245,938 shares of the exchange traded fund’s stock after buying an additional 57,914 shares during the period. First Republic Investment Management Inc. owned approximately 0.28% of SPDR S&P Biotech ETF worth $19,508,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. Moisand Fitzgerald Tamayo LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $30,000. Tyler Stone Wealth Management increased its holdings in SPDR S&P Biotech ETF by 312.5% in the 2nd quarter. Tyler Stone Wealth Management now owns 429 shares of the exchange traded fund’s stock valued at $32,000 after purchasing an additional 325 shares during the last quarter. Evoke Wealth LLC increased its holdings in SPDR S&P Biotech ETF by 423.0% in the 2nd quarter. Evoke Wealth LLC now owns 455 shares of the exchange traded fund’s stock valued at $34,000 after purchasing an additional 368 shares during the last quarter. Charter Oak Capital Management LLC acquired a new stake in SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $34,000. Finally, Ancora Advisors LLC increased its holdings in SPDR S&P Biotech ETF by 47.9% in the 1st quarter. Ancora Advisors LLC now owns 491 shares of the exchange traded fund’s stock valued at $67,000 after purchasing an additional 159 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 1.9 %

SPDR S&P Biotech ETF stock opened at $88.82 on Wednesday. SPDR S&P Biotech ETF has a fifty-two week low of $61.78 and a fifty-two week high of $99.16. The firm has a 50 day moving average price of $82.61 and a 200 day moving average price of $82.97.

About SPDR S&P Biotech ETF

(Get Rating)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.